Kate Rittenhouse-Olson, PhD, professor of biotechnical and clinical laboratory sciences, and Ernesto De Nardin, PhD, adjunct professor of microbiology and immunology, have co-authored a clinical immunology textbook.
Kunle Odunsi, director of RPCI’s Center for Immunotherapy and UB professor of gynecology and obstetrics, is leading a phase 1 clinical trial of the dendritic cell vaccine.
Sanjay Sethi is researching better drugs for COPD; Thomas Russo is exploring new targets for a multidrug-resistant pathogen.
Timothy F. Murphy, MD, has been named director of the UB Clinical and Translational Science Institute, scheduled to open this May on the Buffalo Niagara Medical Campus.
Thomas Melendy, PhD, says the HPV vaccine is safe and effective.
Timothy F. Murphy, MD, senior associate dean for clinical and translational research, has been named a SUNY Distinguished Professor.
Three faculty in the School of Medicine and Biomedical Sciences have been named UB Distinguished Professors for 2011.
Researchers at UB have developed a novel technology that is expected to have implications for research and treatment of tuberculosis and other lung diseases.
A UB MD/PhD candidate is lead author on a paper describing how drug-resistant viruses may be thwarted by a potent, immune-boosting payload delivered to cells by gold nanorods.